These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Use of biofeedback training in treatment of Raynaud's disease and phenomenon. Yocum DE, Hodes R, Sundstrom WR, Cleeland CS. J Rheumatol; 1985 Feb; 12(1):90-3. PubMed ID: 3981523 [Abstract] [Full Text] [Related]
7. [Mucocutaneous lesions in patients with systemic lupus erythematosus]. Saurit V, Campana R, Ruiz Lascano A, Ducasse C, Bertoli A, Agüero S, Alvarellos A, Caeiro F. Medicina (B Aires); 2003 Feb; 63(4):283-7. PubMed ID: 14518140 [Abstract] [Full Text] [Related]
8. Pulmonary hypertension in systemic lupus erythematosus: clinical association and survival in 18 patients. Li EK, Tam LS. J Rheumatol; 1999 Sep; 26(9):1923-9. PubMed ID: 10493670 [Abstract] [Full Text] [Related]
9. Greater accrual damage in late-onset systemic lupus erythematosus: a long-term follow-up study. Appenzeller S, Pereira DA, Costallat LT. Lupus; 2008 Nov; 17(11):1023-8. PubMed ID: 18852227 [Abstract] [Full Text] [Related]
11. [Diagnostic value of thermography in Raynaud's phenomenon associated with systemic lupus erythematosus]. Mikulska D. Ann Acad Med Stetin; 2009 Nov; 55(3):23-7. PubMed ID: 20698174 [Abstract] [Full Text] [Related]
12. Nicardipine for the treatment of Raynaud's phenomena: a double blind crossover trial of a new calcium entry blocker. Rupp PA, Mellinger S, Kohler J, Dorsey JK, Furst DE. J Rheumatol; 1987 Aug; 14(4):745-50. PubMed ID: 3312603 [Abstract] [Full Text] [Related]
13. Prevalence and factors associated with headache in patients with systemic lupus erythematosus. Weder-Cisneros ND, Téllez-Zenteno JF, Cardiel MH, Guibert-Toledano M, Cabiedes J, Velásquez-Paz AL, García-Ramos G, Cantú C. Cephalalgia; 2004 Dec; 24(12):1031-44. PubMed ID: 15566417 [Abstract] [Full Text] [Related]
15. Clinical analysis of systemic lupus erythematosus with gastrointestinal manifestations. Xu D, Yang H, Lai CC, Li P, Zhang X, Yang XO, Zhang FC, Qian JM. Lupus; 2010 Jun; 19(7):866-9. PubMed ID: 20410154 [Abstract] [Full Text] [Related]
16. [Esophageal motility in Raynaud's disease, systemic scleroderma and presclerodermal Raynaud's syndrome]. Hostein J, Bost R, Carpentier P, Franco A, Fournet J. Gastroenterol Clin Biol; 1985 Feb; 9(2):130-5. PubMed ID: 3979734 [Abstract] [Full Text] [Related]
17. Diagnostic algorithm for Raynaud's phenomenon and vascular skin lesions in systemic lupus erythematosus. Richter JG, Sander O, Schneider M, Klein-Weigel P. Lupus; 2010 Aug; 19(9):1087-95. PubMed ID: 20693202 [Abstract] [Full Text] [Related]
18. Time to diagnosis in systemic sclerosis: is sex a factor? Hudson M, Thombs B, Baron M, Canadian Scleroderma Research Group. Arthritis Rheum; 2009 Feb 15; 61(2):274-8. PubMed ID: 19177534 [Abstract] [Full Text] [Related]
19. [Sarpogrelate hydrochloride for Raynaud's phenomenon of patients with collagen diseases]. Kumagai S, Morinobu A, Ozaki S, Nakao K, Ishida H. Ryumachi; 1998 Jun 15; 38(3):504-10. PubMed ID: 9721558 [Abstract] [Full Text] [Related]